Membrane Proteins

Erscheinungsjahr 2022
ISBN: 978-0-323-98895-7
Verlag: William Andrew Publishing

Buch, Englisch, 488 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 880 g

Membrane Proteins, Volume 128 in the Advances in Protein Chemistry and Structural Biology series highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors.

Zielgruppe

This volume would be of great interest to a very wide audience - protein chemists, molecular cell biologists, immunologists, structural biologists, computational biochemists, medical doctors, pharmacologists and other researchers working in the field of transport proteins and drug design. Articles published here would also be of a considerable benefit to medical, biology and pharmacology students specializing in this field.

Autoren/Hrsg.

Donev, Rossen

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Molekularbiologie
• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Biowissenschaften DNA und Transgene Organismen

Inhaltsverzeichnis

1. Architects of their own environment: How membrane proteins shape the Gram-negative cell envelope
Johannes Thoma and Bj?orn M. Burmann
2. Modulation of host cellular responses by gram-negative bacterial porins
Arpita Sharma, Shashi Prakash Yadav, Dwipjyoti Sarma, and Arunika Mukhopadhaya
3. Pore formation by pore forming membrane proteins towards infections
Achinta Sannigrahi and Krishnananda Chattopadhyay
4. Transmembrane ß-barrel proteins of bacteria: From structure to function
Simen Hermansen, Dirk Linke, and Jack C. Leo
5. Ribosome-membrane crosstalk: Co-translational targeting pathways of proteins across membranes in prokaryotes and eukaryotes
Krishnamoorthi Srinivasan, Aneek Banerjee, Priya Baid, Ankit Dhur, and Jayati Sengupta
6. Mechanisms of long-distance allosteric couplings in proton-binding membrane transporters
Ana-Nicoleta Bondar
7. Structures and functions of the membrane-damaging pore-forming proteins
Anish Kumar Mondal and Kausik Chattopadhyay
8. Ganglioside binding domains in proteins: Physiological and pathological mechanisms
Fodil Azzaz, Nouara Yahi, Coralie Di Scala, Henri Chahinian, and Jacques Fantini
9. Development of enhanced conformational sampling methods to probe the activation landscape of GPCRs
Ravinder Abrol, Erik Serrano, and Luis Jaimes Santiago
10. Molecular determinants of GPCR pharmacogenetics: Deconstructing the population variants in ß2-adrenergic receptor
Manali Joshi, Siddhanta V. Nikte, and Durba Sengupta
11. The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins
Bani Kumar Pathak, Sandip Dey, Sukanya Mozumder, and Jayati Sengupta
12. Dendritic spine membrane proteome and its alterations in autistic spectrum disorder
Ana Sofía Vall>es and Francisco J. Barrantes

Über Autor(innen)

Donev, Rossen
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.